This site is intended for healthcare professionals
News

Phase III COUGH-1 and COUGH-2 trials of MK 7264 shows mixed results in chronic cough.- Merck Inc

Read time: 1 mins
Last updated:9th Sep 2020
Published:9th Sep 2020
Condition: Chronic Cough
Type: drug
Register free for full access to medthority.com